Global Nucleic Acid Drugs Competitive Landscape Professional Research Report 2025
Description
Global Nucleic Acid Drugs Competitive Landscape Professional Research Report 2025
Research Summary
Nucleic acid drugs are a class of therapeutic agents that utilize nucleic acids, such as DNA or RNA, to treat diseases by targeting specific genetic sequences or processes within cells. These drugs can modulate gene expression, inhibit the production of disease-causing proteins, or correct genetic mutations responsible for various disorders. There are several types of nucleic acid drugs, including antisense oligonucleotides, small interfering RNA (siRNA), messenger RNA (mRNA), and gene editing tools like CRISPR-Cas9. Antisense oligonucleotides bind to target RNA molecules, preventing their translation into proteins or promoting their degradation. siRNA molecules silence specific genes by triggering RNA interference pathways, while mRNA therapies deliver exogenous mRNA to produce therapeutic proteins within cells. Gene editing tools like CRISPR-Cas9 enable precise modification of DNA sequences to correct genetic mutations or engineer desired changes in the genome. Nucleic acid drugs hold promise for treating a wide range of diseases, including genetic disorders, cancer, viral infections, and inflammatory conditions, offering potential advantages such as specificity, potency, and the ability to target previously ＂undruggable＂ targets. However, challenges remain in optimizing delivery methods, ensuring safety, and overcoming off-target effects to fully realize their therapeutic potential.
According to DIResearch's in-depth investigation and research, the global Nucleic Acid Drugs market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Nucleic Acid Drugs include Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Nucleic Acid Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nucleic Acid Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nucleic Acid Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nucleic Acid Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Nucleic Acid Drugs Include:
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
Nucleic Acid Drugs Product Segment Include:
Antisense Oligonucleotides (ASO)
siRNA
mRNA
Nucleic Acid Drugs Product Application Include:
Neuromuscular Diseases
hATTR
COVID-19
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Nucleic Acid Drugs Industry PESTEL Analysis
Chapter 3: Global Nucleic Acid Drugs Industry Porter’s Five Forces Analysis
Chapter 4: Global Nucleic Acid Drugs Major Regional Market Size and Forecast Analysis
Chapter 5: Global Nucleic Acid Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Nucleic Acid Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Nucleic Acid Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Nucleic Acid Drugs Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Nucleic Acid Drugs Product by Type
- 1.2.1 Antisense Oligonucleotides (ASO)
- 1.2.2 siRNA
- 1.2.3 mRNA
- 1.3 Nucleic Acid Drugs Product by Application
- 1.3.1 Neuromuscular Diseases
- 1.3.2 hATTR
- 1.3.3 COVID-19
- 1.3.4 Others
- 1.4 Global Nucleic Acid Drugs Market Size Analysis (2020-2032)
- 1.5 Nucleic Acid Drugs Market Development Status and Trends
- 1.5.1 Nucleic Acid Drugs Industry Development Status Analysis
- 1.5.2 Nucleic Acid Drugs Industry Development Trends Analysis
- 2 Nucleic Acid Drugs Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Nucleic Acid Drugs Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Nucleic Acid Drugs Market Analysis by Regions
- 4.1 Nucleic Acid Drugs Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Nucleic Acid Drugs Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Nucleic Acid Drugs Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Nucleic Acid Drugs Revenue Forecast by Region (2026-2032)
- 5 Global Nucleic Acid Drugs Market Size by Type and Application
- 5.1 Global Nucleic Acid Drugs Market Size by Type (2020-2032)
- 5.2 Global Nucleic Acid Drugs Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Nucleic Acid Drugs Market Size by Type
- 6.4 North America Nucleic Acid Drugs Market Size by Application
- 6.5 North America Nucleic Acid Drugs Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Nucleic Acid Drugs Market Size by Type
- 7.4 Europe Nucleic Acid Drugs Market Size by Application
- 7.5 Europe Nucleic Acid Drugs Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Nucleic Acid Drugs Market Size by Type
- 8.4 China Nucleic Acid Drugs Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Nucleic Acid Drugs Market Size by Type
- 9.4 APAC (excl. China) Nucleic Acid Drugs Market Size by Application
- 9.5 APAC (excl. China) Nucleic Acid Drugs Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Nucleic Acid Drugs Market Size by Type
- 10.4 Latin America Nucleic Acid Drugs Market Size by Application
- 10.5 Latin America Nucleic Acid Drugs Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Nucleic Acid Drugs Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Nucleic Acid Drugs Market Size by Type
- 11.4 Middle East & Africa Nucleic Acid Drugs Market Size by Application
- 11.5 Middle East & Africa Nucleic Acid Drugs Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Nucleic Acid Drugs Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Nucleic Acid Drugs Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Nucleic Acid Drugs Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sarepta Therapeutics
- 13.1.1 Sarepta Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Portfolio
- 13.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Ionis Pharmaceuticals
- 13.2.1 Ionis Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Portfolio
- 13.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Alnylam
- 13.3.1 Alnylam Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Alnylam Nucleic Acid Drugs Product Portfolio
- 13.3.3 Alnylam Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Biogen
- 13.4.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Biogen Nucleic Acid Drugs Product Portfolio
- 13.4.3 Biogen Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Nippon Shinyaku
- 13.5.1 Nippon Shinyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Nippon Shinyaku Nucleic Acid Drugs Product Portfolio
- 13.5.3 Nippon Shinyaku Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Sobi
- 13.6.1 Sobi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Sobi Nucleic Acid Drugs Product Portfolio
- 13.6.3 Sobi Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Novartis
- 13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Novartis Nucleic Acid Drugs Product Portfolio
- 13.7.3 Novartis Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 BioNTech
- 13.8.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 BioNTech Nucleic Acid Drugs Product Portfolio
- 13.8.3 BioNTech Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Pfizer
- 13.9.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Pfizer Nucleic Acid Drugs Product Portfolio
- 13.9.3 Pfizer Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Moderna Therapeutics
- 13.10.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Moderna Therapeutics Nucleic Acid Drugs Product Portfolio
- 13.10.3 Moderna Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Jazz Pharmaceuticals
- 13.11.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Jazz Pharmaceuticals Nucleic Acid Drugs Product Portfolio
- 13.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 CureVac
- 13.12.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 CureVac Nucleic Acid Drugs Product Portfolio
- 13.12.3 CureVac Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Regulus Therapeutics
- 13.13.1 Regulus Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Regulus Therapeutics Nucleic Acid Drugs Product Portfolio
- 13.13.3 Regulus Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 ProQR
- 13.14.1 ProQR Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 ProQR Nucleic Acid Drugs Product Portfolio
- 13.14.3 ProQR Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Secarna
- 13.15.1 Secarna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Secarna Nucleic Acid Drugs Product Portfolio
- 13.15.3 Secarna Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 MiNA Therapeutics
- 13.16.1 MiNA Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 MiNA Therapeutics Nucleic Acid Drugs Product Portfolio
- 13.16.3 MiNA Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Sylentis
- 13.17.1 Sylentis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Sylentis Nucleic Acid Drugs Product Portfolio
- 13.17.3 Sylentis Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 Arrowhead
- 13.18.1 Arrowhead Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 Arrowhead Nucleic Acid Drugs Product Portfolio
- 13.18.3 Arrowhead Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.19 Silence Therapeutics
- 13.19.1 Silence Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Silence Therapeutics Nucleic Acid Drugs Product Portfolio
- 13.19.3 Silence Therapeutics Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.20 Dicerna
- 13.20.1 Dicerna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 Dicerna Nucleic Acid Drugs Product Portfolio
- 13.20.3 Dicerna Nucleic Acid Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Nucleic Acid Drugs Industry Chain Analysis
- 14.2 Nucleic Acid Drugs Industry Raw Material and Suppliers Analysis
- 14.2.1 Nucleic Acid Drugs Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Nucleic Acid Drugs Typical Downstream Customers
- 14.4 Nucleic Acid Drugs Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
